http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004037807-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8584c6ad09c6b5959db6699842c19b5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed658b7cdca7e52fa2e237f424f5fc14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
filingDate 2003-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddaa755836d3cec6aa3449fe6035f71c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_427de8eef512205c897af1178184a40f
publicationDate 2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004037807-A3
titleOfInvention Medicinal arylethanolamine compounds
abstract The present invention relates to novel compounds of formula (I), and salts, solvates and physiologically acceptable derivatives thereof, to a process for their manufacture, to pharmaceutical compositions containing them, and to their use in therapy, in particular their use in the prophylaxis and treatment of respiratory diseases.
priorityDate 2002-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9829405-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415830407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415742896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467766475
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465565385
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69521

Total number of triples: 38.